BT-2

N/A

Report date: 2024/06/21 12:45:27
NME

Base Information

Drug NameBT-2
Drug Alias NameOral BCKDK inhibitors (Ramino Bio)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBranched-chain alpha-ketoacid dehydrogenase kinase inhibitors
TargetsBranched-chain alpha-ketoacid dehydrogenase kinase
Therapy Area/IndicationsMetabolic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsMetabolic Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A